glp-1 consultation Telehealth Monitoring for Safer Remote Care GLP-1 Weight Loss Meds in

Whether these differences can explain metabolic outcomes will be explored in detail below (Figure 2)

The Average Weight Loss for GLP-1 Users was 24.9 lbs GLP-1 users reported an average weight loss of 24.9 lbs, and a median weight loss of 20 lbs

Comparative studies indicate semaglutide producing a 15.8 percent mean weight loss at 68 weeks versus 6.4 percent with liraglutide, emphasizing its strong and sustained impact on weight management

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss

Thus, one explanation for the lack of differences observed in perceptions of the targets SES is that the high costs of GLP-1s may not have been widely known among our participants

For example, before the price decreases, the cost of GLP-1 receptor agonists had been compared to bariatric surgery, with GLP-1s representing an ongoing monthly expense while surgery involves a high upfront cost